Cat: IPD-X40699

Recombinant Human C12orf49 Protein ,His & SUMO

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    C12orf49

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    C12orf49UPF0454 protein C12orf49

  • Species

    Human

  • Source

    E. coli

  • Tag

    N- His-SUMO

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q9H741

  • Expression Region

    34-205aa

  • Molecular Weight

    35.7 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

C12orf49, also known as a candidate gene located on chromosome 12, has emerged as a subject of interest in various biological and pathological studies. Initially identified through genomic studies, C12orf49 is believed to play a role in cellular processes such as proliferation, apoptosis, and immune response. Recent research has highlighted its potential implications in certain diseases, particularly in cancer and autoimmune disorders, suggesting that variations in C12orf49 expression could influence disease susceptibility and progression. The recombinant protein version of C12orf49 has been developed to facilitate detailed studies on its biological functions and interactions at the molecular level. This recombinant protein serves as a useful tool for investigating the protein's structure, post-translational modifications, and its role in signaling pathways. Understanding the function and mechanisms of C12orf49 may provide valuable insights into therapeutic targets and strategies for managing diseases associated with its dysregulation. The ongoing research into C12orf49 and its recombinant protein forms underscores the significance of elucidating the roles of lesser-known proteins in health and disease contexts.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US